PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42
about
Lipid peroxidation and its toxicological implicationsFuture technology insight: mass spectrometry imaging as a tool in drug research and development.Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipidsAbeta mediated diminution of MTT reduction--an artefact of single cell culture?Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice.Characterization of scavengers of gamma-ketoaldehydes that do not inhibit prostaglandin biosynthesis.On-tissue chemical derivatization of 3-methoxysalicylamine for MALDI-imaging mass spectrometryDetermination of 3-methoxysalicylamine levels in mouse plasma and tissue by liquid chromatography-tandem mass spectrometry: application to in vivo pharmacokinetics studiesReactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cells.Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.A new mechanism links preamyloid oligomer formation in the myocyte stress response associated with atrial fibrillation.Determination of the Pharmacokinetics and Oral Bioavailability of Salicylamine, a Potent γ-Ketoaldehyde Scavenger, by LC/MS/MS.The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.Isoprostane generation and function.Isolevuglandin adducts in diseaseIsolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.Formation of gamma-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice.Soluble state high resolution atomic force microscopy study of Alzheimer's beta-amyloid oligomers.Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling.Alzheimer's Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station.Molecular Structures of Isolevuglandin-Protein Cross-Links.Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D2.
P2860
Q27691302-22C11DD2-465A-4ADE-994A-E86A6FF51309Q28087460-F8253CAD-2D88-4616-A5C8-F3BA4CF5E6DCQ28389004-386DD06B-A673-4DCC-BA9D-BD3FF1C697FCQ28473625-00D37D5C-9DC2-445A-A6D8-761B06840A42Q30505920-80DAB424-D344-4C82-9036-25A48F0B13A9Q33701495-561D0C7A-33C3-4F93-96B6-E44690FE4651Q33990585-65080B23-DBD7-491C-8A86-C88AF5F36A29Q34965048-57901ACF-D148-49A2-B80B-0EEA5DF517AFQ34995740-19A67DA0-D831-4AC1-8C9C-BA796B108E2DQ35126030-7B38F6B7-D3D9-40D5-8DA2-438391D61B4CQ35137541-0A43D21B-A59A-4B66-B575-CBC76E773ADFQ35148031-333A4366-4275-4502-A425-0260E92F1E83Q35327219-B453C4C1-B326-4341-8D07-E2EA81E24F93Q35332267-2B2E0455-913B-479B-8E10-90A7222710A3Q35794678-E77A8B94-D275-464B-A101-531E0B528EACQ37438010-7FB8B6FC-CA9C-4FF4-BA3A-3099FBC80386Q37438265-99EBE3D2-BAF0-4005-AC1A-4C5D51F2ED36Q37460809-15972291-E50A-49E0-AA7B-5CDCCB0E675DQ37717636-7FB5D0F4-265A-40F8-B21D-D491C2B1519FQ37724402-890AF9F2-7581-44A6-822F-F8DC6365B69DQ42214486-58BBB494-B312-4215-9294-BC03953C3E14Q48239770-D57D3386-086A-4A6C-990C-5D5EB525DF13
P2860
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42
@ast
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42
@en
type
label
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42
@ast
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42
@en
prefLabel
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42
@ast
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42
@en
P2093
P2860
P1476
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42
@en
P2093
John A Oates
Olivier Boutaud
Thomas J Montine
William L Klein
P2860
P304
P356
10.1111/J.1471-4159.2005.03586.X
P407
P577
2006-01-12T00:00:00Z